SCHEMBL6379245

SCHEMBL6379245

CC(C)C1(Oc2ccc(OCc3ccc(F)cc3)cc2)C(=O)NC(=O)NC1=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.48
▸ CTSB P07858 1/20 0.48
▸ MAOB P27338 10/20 0.47
▸ MMP13 P45452 2/20 0.46
▸ MMP2 P08253 1/20 0.46
▸ APP P05067 1/20 0.46
▸ PTPN1 P18031 1/20 0.45
▸ FFAR1 O14842 1/20 0.45
▸ NR4A2 P43354 1/20 0.45
▸ MAOA P21397 1/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA7 P43166 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ PARP10 Q53GL7 1/20 0.44
▸ ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6383331 0.83 MMP13 (0.54) CTSLCTSBMAOBMMP13MMP2
SCHEMBL6377388 0.81 MAOB (0.49) CTSLCTSBMAOBMMP13MMP2
SCHEMBL6378913 0.81 MMP13 (0.56) CTSLCTSBMAOBMMP13MMP2
SCHEMBL6379256 0.79 MMP13 (0.59) CTSLCTSBMMP13
SCHEMBL6379189 0.78 CTSL (0.49) CTSLCTSBMAOBMMP13MMP2
SCHEMBL6379044 0.78 MMP13 (0.50) CTSLCTSBMAOBMMP13MMP2
SCHEMBL6380903 0.77 MMP13 (0.46) CTSLCTSBMAOBMMP13MMP2
SCHEMBL6375133 0.76 CA12 (0.56) CTSLCTSBMAOBMMP13MMP2
SCHEMBL6377050 0.76 MMP13 (0.54) CTSLCTSBMAOBMMP13MMP2
SCHEMBL6378753 0.74 MMP13 (0.49) CTSLCTSBMAOBMMP13MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202974-B1 PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS PFIZER PROD INC (US) 2005-11-09 — — EP disclosed
US-6579982-B1 Treating inflammation, cancer PFIZER INC. 2003-06-17 — — US disclosed
Send feedback